f1
Correspondence: Silvia G. Priori, MD, PhD, FESC, Chairman Task Force on Sudden Cardiac Death, European Society of Cardiology, Fondazione Salvatore Maugeri, University of Pavia, Via Ferrata 8, 27100 Pavia, Italy. E-mail:spriori@fsm.it

References

1
Myerburg
RJ
, Castellanos A. Cardiac arrest and sudden cardiac death. Braunwald E. Heart disease: a textbook of cardiovascular medicine. New York:: WB Saunders Publishing Co; 1997. p. 742–779
2
Hinkle
LE
, Thaler HT. Clinical classification of cardiac deaths.
Circulation
 .
1982
;
65
:
457
–464
3
Pratt
CM
, Greenway PS, Schoenfeld MH, Hibben ML, Reiffel JA. Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials.
Circulation
 .
1996
;
93
:
519
–524
4
Narang
R
, Cleland JG, Erhardt L. Mode of death in chronic heart failure. A request and proposition for more accurate classification.
Eur Heart J
 .
1996
;
17
:
1390
–1403
5
Thomas
AC
, Knapman PA, Krikler DM, Davies MJ. Community study of the causes of ‘natural’ sudden death.
BMJ
 .
1988
;
297
:
1453
–1456
6
Leach
IH
, Blundell JW, Rowley JM, Turner DR. Acute ischaemic lesions in death due to ischaemic heart disease. An autopsy study of 333 cases of out-of-hospital death.
Eur Heart J
 .
1995
;
16
:
1181
–1185
7
Goraya
TY
, Jacobsen SJ, Belau PG, Weston SA, Kottke TE, Roger VL. Validation of death certificate diagnosis of out-of-hospital coronary heart disease deaths in Olmsted County, Minnesota.
Mayo Clin Proc
 .
2000
;
75
:
681
–687
8
Davies
MJ
, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death.
N Engl J Med
 .
1984
;
310
:
1137
–1140
9
Carveth
SW
, Olson D, Bechtel J. Proceedings: Emergency medical care system. Lincoln (Beb) mobile heart team.
Arch Surg
 .
1974
;
108
:
528
–530
10
Vertesi
L
. The paramedic ambulance: a Canadian experience.
Can Med Assoc J
 .
1978
;
119
:
25
–29
11
Bachman
JW
, McDonald GS, O'Brien PC. A study of out-of-hospital cardiac arrests in northeastern Minnesota.
JAMA
 .
1986
;
256
:
477
–483
12
Becker
LB
, Smith DW, Rhodes KV. Incidence of cardiac arrest: a neglected factor in evaluating survival rates.
Ann Emerg Med
 .
1993
;
22
:
86
–91
13
Sans
S
, Kesteloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe.
Eur Heart J
 .
1997
;
18
:
1231
–1248
14
Vreede-Swagemakers
JJ
, Gorgels AP, Dubois-Arbouw WI. Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival.
J Am Coll Cardiol
 .
1997
;
30
:
1500
–1505
15
Myerburg
RJ
, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk.
Circulation
 .
1992
;
85
:
I2
–10
16
Gillum
RF
. Sudden coronary death in the United States: 1980–1985.
Circulation
 .
1989
;
79
:
756
–765
17
Kannel, WB, Abbott, RD, Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study, N Engl J Med 1984, 311, 1144, 47
18
McDonagh
TA
, Morrison CE, Lawrence A. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population.
Lancet
 .
1997
;
350
:
829
–833
19
Cupples
LA
, Gagnon DR, Kannel WB. Long- and short-term risk of sudden coronary death.
Circulation
 .
1992
;
85
:
I11
–I18
20
Wannamethee
G
, Shaper AG, Macfarlane PW, Walker M. Risk factors for sudden cardiac death in middle-aged British men.
Circulation
 .
1995
;
91
:
1749
–1756
21
Sexton
PT
, Walsh J, Jamrozik K, Parsons R. Risk factors for sudden unexpected cardiac death in Tasmanian men.
Aust N Z J Med
 .
1997
;
27
:
45
–50
22
Jouven
X
, Desnos M, Guerot C, Ducimetiere P. Predicting sudden death in the population: the Paris Prospective Study I.
Circulation
 .
1999
;
99
:
1978
–1983
23
Kannel
WB
, Gagnon DR, Cupples LA. Epidemiology of sudden coronary death: population at risk.
Can J Cardiol
 .
1990
;
6
:
439
–444
24
Algra
A
, Tijssen JG, Roelandt JR, Pool J, Lubsen J. Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death.
Circulation
 .
1993
;
88
:
180
–185
25
Shaper
AG
, Wannamethee G, Macfarlane PW, Walker M. Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men.
Br Heart J
 .
1993
;
70
:
49
–55
26
Kannel
WB
, Cupples LA, D'Agostino RB, Stokes J. Hypertension, antihypertensive treatment, and sudden coronary death. The Framingham Study.
Hypertension
 .
1988
;
11
:
II45
–II50
27
Weijenberg
MP
, Feskens EJ, Kromhout D. Blood pressure and isolated systolic hypertension and the risk of coronary heart disease and mortality in elderly men (the Zutphen Elderly Study).
J Hypertens
 .
1996
;
14
:
1159
–1166
28
Kannel
WB
. Left ventricular hypertrophy as a risk factor: the Framingham experience.
J Hypertens Suppl
 .
1991
;
9
:
S3
–S8
29
Clark
LT
. Anatomic substrate differences between black and white victims of sudden cardiac death: hypertension, coronary artery disease, or both?
Clin Cardiol
 .
1989
;
12
:
IV13
–IV17
30
Haider
AW
, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death.
J Am Coll Cardiol
 .
1998
;
32
:
1454
–1459
31
Staessen
JA
, Wang JG, Thijs L, Fagard R. Overview of the outcome trials in older patients with isolated systolic hypertension.
J Hum Hypertens
 .
1999
;
13
:
859
–863
32
Collins
R
, Peto R, MacMahon S. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.
Lancet
 .
1990
;
335
:
827
–838
33
Shepherd
J
, Cobbe SM, Ford I. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia.
N Engl J Med
 .
1995
;
333
:
1301
–1307
34
Downs
JR
, Clearfield M, Weis S. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
JAMA
 .
1998
;
279
:
1615
–1622
35
Circulation
 .
1994
;
89
:
1333
–1445
36
Albert
CM
, Hennekens CH, O'Donnell CJ. Fish consumption and risk of sudden cardiac death.
JAMA
 .
1998
;
279
:
23
–28
37
Burke
AP
, Farb A, Malcom GT, Liang Y, Smialek JE, Virmani R. Plaque rupture and sudden death related to exertion in men with coronary artery disease.
JAMA
 .
1999
;
281
:
921
–926
38
Lemaitre
RN
, Siscovick DS, Raghunathan TE, Weinmann S, Arbogast P, Lin DY. Leisure-time physical activity and the risk of primary cardiac arrest.
Arch Intern Med
 .
1999
;
159
:
686
–690
39
Scragg
R
, Stewart A, Jackson R, Beaglehole R. Alcohol and exercise in myocardial infarction and sudden coronary death in men and women.
Am J Epidemiol
 .
1987
;
126
:
77
–85
40
Aberg
H
, Lithell H, Selinus I, Hedstrand H. Alcohol intemperance and social disability as risk factors for different causes of death.
Acta Med Scand
 .
1986
;
220
:
351
–359
41
Day
CP
, James OF, Butler TJ, Campbell RW. QT prolongation and sudden cardiac death in patients with alcoholic liver disease.
Lancet
 .
1993
;
341
:
1423
–1428
42
Vreede-Swagemakers
JJ
, Gorgels AP, Weijenberg MP. Risk indicators for out-of-hospital cardiac arrest in patients with coronary artery disease.
J Clin Epidemiol
 .
1999
;
52
:
601
–607
43
Palatini
P
, Casiglia E, Julius S, Pessina AC. High heart rate: a risk factor for cardiovascular death in elderly men.
Arch Intern Med
 .
1999
;
159
:
585
–592
44
Dekker
JM
, Schouten EG, Klootwijk P, Pool J, Swenne CA, Kromhout D. Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen Study.
Am J Epidemiol
 .
1997
;
145
:
899
–908
45
Kannel
WB
, Schatzkin A. Sudden death: lessons from subsets in population studies.
J Am Coll Cardiol
 .
1985
;
5
:
141B
–149B
46
Escobedo
LG
, Caspersen CJ. Risk factors for sudden coronary death in the United States.
Epidemiology
 .
1997
;
8
:
175
–180
47
Escobedo
LG
, Zack MM. Comparison of sudden and nonsudden coronary deaths in the United States.
Circulation
 .
1996
;
93
:
2033
–2036
48
Hallstrom
AP
, Cobb LA, Ray R. Smoking as a risk factor for recurrence of sudden cardiac arrest.
N Engl J Med
 .
1986
;
314
:
271
–275
49
Curb
JD
, Rodriguez BL, Burchfiel CM, Abbott RD, Chiu D, Yano K. Sudden death, impaired glucose tolerance, and diabetes in Japanese American men.
Circulation
 .
1995
;
91
:
2591
–2595
50
Suhonen
O
, Reunanen A, Knekt P, Aromaa A. Risk factors for sudden and non-sudden coronary death.
Acta Med Scand
 .
1988
;
223
:
19
–25
51
De Bacquer
D
, De Backer G, Kornitzer M, Myny K, Doyen Z, Blackburn H. Prognostic value of ischemic electrocardiographic findings for cardiovascular mortality in men and women.
J Am Coll Cardiol
 .
1998
;
32
:
680
–685
52
Kors
JA
, de Bruyne MC, Hoes AW. T-loop morphology as a marker of cardiac events in the elderly.
J Electrocardiol
 .
1998
;
31
:
54
–59
53
Burton
F
, Cobbe SM. Dispersion of ventricular repolarization and refractoriness.
Cardiovas Res
 .
2001
;
50
:
10
–23
54
Schouten
EG
, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population.
Circulation
 .
1991
;
84
:
1516
–1523
55
Dekker
JM
, Schouten EG, Klootwijk P, Pool J, Kromhout D. Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study.
Circulation
 .
1994
;
90
:
779
–785
56
de Bruyne
MC
, Hoes AW, Kors JA, Hofman A, van Bemmel JH, Grobbee DE. QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study.
Circulation
 .
1998
;
97
:
467
–472
57
Manttari
M
, Oikarinen L, Manninen V, Viitasalo M. QT dispersion as a risk factor for sudden cardiac death and fatal myocardial infarction in a coronary risk population.
Heart
 .
1997
;
78
:
268
–272
58
Friedlander
Y
, Siscovick DS, Weinmann S. Family history as a risk factor for primary cardiac arrest.
Circulation
 .
1998
;
97
:
155
–160
59
Milner
PG
, Platia EV, Reid PR, Griffith LS. Ambulatory electrocardiographic recordings at the time of fatal cardiac arrest.
Am J Cardiol
 .
1985
;
56
:
588
–592
60
Marcus
FI
, Cobb LA, Edwards JE. Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarction.
Am J Cardiol
 .
1988
;
61
:
8
–15
61
Hohnloser
SH
, Klingenheben T, Zabel M, Schopperl M, Mauss O. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era.
J Am Coll Cardiol
 .
1999
;
33
:
1895
–1902
62
Statters
DJ
, Malik M, Redwood S, Hnatkova K, Staunton A, Camm AJ. Use of ventricular premature complexes for risk stratification after acute myocardial infarction in the thrombolytic era.
Am J Cardiol
 .
1996
;
77
:
133
–138
63
Farb
A
, Tang AL, Burke AP, Sessums L, Liang Y, Virmani R. Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction.
Circulation
 .
1995
;
92
:
1701
–1709
64
Patterson
E
, Holland K, Eller BT, Lucchesi BR. Ventricular fibrillation resulting from ischemia at a site remote from previous myocardial infarction. A conscious canine model of sudden coronary death.
Am J Cardiol
 .
1982
;
50
:
1414
–1423
65
Di Maio
VJ
, Di Maio DJ. Incidence of coronary thrombosis in sudden death due to coronary artery disease.
Am J Forensic Med Pathol
 .
1993
;
14
:
273
–275
66
Davies
MJ
, Bland JM, Hangartner JR, Angelini A, Thomas AC. Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death.
Eur Heart J
 .
1989
;
10
:
203
–208
67
Bayes
dL
, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases.
Am Heart J
 .
1989
;
117
:
151
–159
68
Myerburg
RJ
, Kessler KM, Zaman L, Conde CA, Castellanos A. Survivors of prehospital cardiac arrest.
JAMA
 .
1982
;
247
:
1485
–1490
69
Luu
M
, Stevenson WG, Stevenson LW, Baron K, Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure.
Circulation
 .
1989
;
80
:
1675
–1680
70
Panidis
IP
, Morganroth J. Sudden death in hospitalized patients: cardiac rhythm disturbances detected by ambulatory electrocardiographic monitoring.
J Am Coll Cardiol
 .
1983
;
2
:
798
–805
71
Roelandt
J
, Klootwijk P, Lubsen J, Janse MJ. Sudden death during longterm ambulatory monitoring.
Eur Heart J
 .
1984
;
5
:
7
–20
72
Kempf
FC
Jr
, Josephson ME. Cardiac arrest recorded on ambulatory electrocardiograms.
Am J Cardiol
 .
1984
;
53
:
1577
–1582
73
Zehender
M
, Buchner C, Meinertz T, Just H. Prevalence, circumstances, mechanisms, and risk stratification of sudden cardiac death in unipolar single-chamber ventricular pacing.
Circulation
 .
1992
;
85
:
596
–605
74
Lancet
 .
1999
;
353
:
2001
–2007
75
Rankin
AS
, Cobbe SM. Arrhythmias and sudden death in heart failure: can we prevent them? McMurray JJV, Cleland. Heart failure in clinical practice. London: Martin Dunitz Ltd; 1996. p. 189–205
76
Uretsky
BF
, Thygesen K, Armstrong PW. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial.
Circulation
 .
2000
;
102
:
611
–616
77
Kjekshus
J
. Arrhythmias and mortality in congestive heart failure.
Am J Cardiol
 .
1990
;
65
:
42I
–48I
78
Yap
Y
, Duong T, Bland M. Left ventricular ejection fraction in the trombolytic era remains a powerful predictor of long-term but not short-term all-cause, cardiac and arrhythmic mortality after myocardial infarction–a secondary meta-analysis of 2828 patients.
Heart
 .
2000
;
83
:
55
79
Stevenson
WG
, Ridker PM. Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists?
JAMA
 .
1996
;
276
:
481
–485
80
Copie
X
, Hnatkova K, Staunton A, Fei L, Camm AJ, Malik M. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study.
J Am Coll Cardiol
 .
1996
;
27
:
270
–276
81
La Rovere
MT
, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction.
Lancet
 .
1998
;
351
:
478
–484
82
White
HD
, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.
Circulation
 .
1987
;
76
:
44
–51
83
Nicolosi
GL
, Latini R, Marino P. The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction in the GISSI-3 Trial.
Eur Heart J
 .
1996
;
17
:
1646
–1656
84
Maggioni
AP
, Zuanetti G, Franzosi MG. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results.
Circulation
 .
1993
;
87
:
312
–322
85
Farrell
TG
, Bashir Y, Cripps T. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram.
J Am Coll Cardiol
 .
1991
;
18
:
687
–697
86
McClements
BM
, Adgey AA. Value of signal-averaged electrocardiography, radionuclide ventriculography, Holter monitoring and clinical variables for prediction of arrhythmic events in survivors of acute myocardial infarction in the thrombolytic era.
J Am Coll Cardiol
 .
1993
;
21
:
1419
–1427
87
Richards
DA
, Byth K, Ross DL, Uther JB. What is the best predictor of spontaneous ventricular tachycardia and sudden death after myocardial infarction?
Circulation
 .
1991
;
83
:
756
–763
88
Mushlin
AI
, Hall WJ, Zwanziger J. The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial.
Circulation
 .
1998
;
97
:
2129
–2135
89
Buxton
AE
, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease.
N Engl J Med
 .
1999
;
341
:
1882
–1890
90
Andresen
D
, Steinbeck G, Bruggemann T. Can the MADIT results be applied to myocardial infarction patients at hospital discharge?
J Am Coll Cardiol
 .
1998
;
31
:
308
91
Steinberg
JS
, Regan A, Sciacca RR, Bigger JT Jr, Fleiss JL. Predicting arrhythmic events after acute myocardial infarction using the signal-averaged electrocardiogram.
Am J Cardiol
 .
1992
;
69
:
13
–21
92
Steinberg
JS
, Hochman JS, Morgan CD. Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial.
Circulation
 .
1994
;
90
:
746
–752
93
Malik
M
, Kulakowski P, Odemuyiwa O. Effect of thrombolytic therapy on the predictive value of signal-averaged electrocardiography after acute myocardial infarction.
Am J Cardiol
 .
1992
;
70
:
21
–25
94
Hermosillo
AG
, Araya V, Casanova JM. Risk stratification for malignant arrhythmic events in patients with an acute myocardial infarction: role of an open infarct-related artery and the signal-averaged ECG.
Coron Artery Dis
 .
1995
;
6
:
973
–983
95
Cain
ME
, Anderon JL, Arnsdorf MF, Mason JW, Scheinman MM, Waldo AL. ACC Consensus Document on Signal-Averaged Electrocardiography.
J Am Coll Cardiol
 .
1996
;
27
:
238
–249
96
Zuanetti
G
, Neilson JM, Latini R, Santoro E, Maggioni AP, Ewing DJ. Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico.
Circulation
 .
1996
;
94
:
432
–436
97
Malik
M
, Camm AJ, Janse MJ, Julian DG, Frangin GA, Schwartz PJ. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial).
J Am Coll Cardiol
 .
2000
;
35
:
1263
–1275
98
Schmidt
G
, Malik M, Barthel P. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction.
Lancet
 .
1999
;
353
:
1390
–1396
99
Schwartz
PJ
, Wolf S. QT interval prolongation as predictor of sudden death in patients with myocardial infarction.
Circulation
 .
1978
;
57
:
1074
–1077
100
Algra
A
, Tijssen JG, Roelandt JR, Pool J, Lubsen J. QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest.
Circulation
 .
1991
;
83
:
1888
–1894
101
Zabel
M
, Klingenheben T, Franz MR, Hohnloser SH. Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction: results of a prospective, long-term follow-up study.
Circulation
 .
1998
;
97
:
2543
–2550
102
Hohnloser
SH
, Klingenheben T, Li YG, Zabel M, Peetermans J, Cohen RJ. T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk markers.
J Cardiovasc Electrophysiol
 .
1998
;
9
:
1258
–1268
103
Ikeda
T
, Sakata T, Takami M. Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study.
J Am Coll Cardiol
 .
2000
;
35
:
722
–730
104
Peterson
ED
, Shaw LJ, Califf RM. Risk stratification after myocardial infarction.
Ann Intern Med
 .
1997
;
126
:
561
–582
105
Wellens
HJ
, Doevendans P, Smeets J. Arrhythmia risk: electrophysiological studies and monophasic action potentials.
Pacing Clin Electrophysiol
 .
1997
;
20
:
2560
–2565
106
Caruso
AC
, Marcus FI, Hahn EA, Hartz VL, Mason JW. Predictors of arrhythmic death and cardiac arrest in the ESVEM trial. Electrophysiologic Study Versus Electromagnetic Monitoring.
Circulation
 .
1997
;
96
:
1888
–1892
107
Andresen
D
, Steinbeck G, Bruggemann T. Risk stratification following myocardial infarction in the thrombolytic era: a two-step strategy using noninvasive and invasive methods.
J Am Coll Cardiol
 .
1999
;
33
:
131
–138
108
Hohnloser
SH
, Franck P, Klingenheben T, Zabel M, Just H. Open infarct artery, late potentials, and other prognostic factors in patients after acute myocardial infarction in the thrombolytic era. A prospective trial.
Circulation
 .
1994
;
90
:
1747
–1756
109
de Chillou
C
, Sadoul N, Bizeau O. Prognostic value of thrombolysis, coronary artery patency, signal-averaged electrocardiography, left ventricular ejection fraction, and Holter electrocardiographic monitoring for life-threatening ventricular arrhythmias after a first acute myocardial infarction.
Am J Cardiol
 .
1997
;
80
:
852
–858
110
N Engl J Med
 .
1989
;
320
:
618
–627
111
Michels
KB
, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials.
Circulation
 .
1995
;
91
:
476
–485
112
Eur Heart J
 .
1996
;
17
:
43
–63
113
Circulation
 .
1998
;
97
:
2202
–2212
114
Ziesche
S
, Rector ST, Cohn JN. Interobserver discordance in the classification of mechanisms of death in studies of heart failure.
J Card Fail
 .
1995
;
1
:
127
–132
115
Cohn
JN
, Johnson G, Ziesche S. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.
N Engl J Med
 .
1991
;
325
:
303
–310
116
N Engl J Med
 .
1991
;
325
:
293
–302
117
Hennekens
CH
, Albert CM, Godfried SL, Gaziano JM, Buring JE. Adjunctive drug therapy of acute myocardial infarction—evidence from clinical trials.
N Engl J Med
 .
1996
;
335
:
1660
–1667
118
Domanski
MJ
, Exner DV, Borkowf CB, Geller NL, Rosenberg Y, Pfeffer MA. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials.
J Am Coll Cardiol
 .
1999
;
33
:
598
–604
119
Pitt
B
, Zannad F, Remme WJ. The effect of spironolactone on morbidity and mortality in patients with severe heart failure.
N Engl J Med
 .
1999
;
341
:
709
–717
120
LaRosa
JC
, He J, Vupputuri S. Effect of statins on risk of coronary disease. A meta-analysis of randomized controlled trials.
JAMA
 .
1999
;
282
:
2340
–2346
121
Lancet
 .
1999
;
354
:
447
–455
122
Lancet
 .
1994
;
343
:
311
–322
123
Lancet
 .
1988
;
2
:
349
–360
124
Topol
EJ
, Mark DB, Lincoff AM. Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting.
Lancet
 .
1999
;
354
:
2019
–2024
125
Anand
SS
, Yusuf S. Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.
JAMA
 .
1999
;
282
:
2058
–2067
126
Collins
R
, MacMahon S, Flather M. Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials.
BMJ
 .
1996
;
313
:
652
–659
127
Weaver
WD
, Simes RJ, Betriu A. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.
JAMA
 .
1997
;
278
:
2093
–2098
128
Ambrosioni
E
, Borghi C, Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction.
N Engl J Med
 .
1995
;
332
:
80
–85
129
Flather
MD
, Yusuf S, Kober L. Long-term ACE-inhibitor therapy in patients with heart failure or left ventricular dysfunction: a systematic overview of data from individual patients.
Lancet
 .
2000
;
355
:
1575
–1581
130
Lancet
 .
1993
;
342
:
821
–828
131
Kober
L
, Torp-Pedersen C, Carlsen JE. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction.
N Engl J Med
 .
1995
;
333
:
1670
–1676
132
Pfeffer
MA
, Braunwald E, Moye LA. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial.
N Engl J Med
 .
1992
;
327
:
669
–677
133
Lancet
 .
1995
;
345
:
669
–685
134
Lancet
 .
1994
;
343
:
1115
–1122
135
N Engl J Med
 .
1992
;
327
:
685
–691
136
N Engl J Med
 .
1987
;
316
:
1429
–1435
137
Zannad
F
, Alla F, Dousset B, Perez A, Pitt B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure : insights from the Randomized Aldactone Evaluation Study (RALES).
Circulation
 .
2000
;
102
:
2700
–2706
138
Lancet
 .
1994
;
344
:
1383
–1389
139
Sacks
FM
, Pfeffer MA, Moye LA. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels.
N Engl J Med
 .
1996
;
335
:
1001
–1009
140
N Engl J Med
 .
1998
;
339
:
1349
–1357
141
Marchioli
R
, Valagussa F. The results of the GISSI-Prevenzione trial in the general framework of secondary prevention.
Eur Heart J
 .
2000
;
21
:
949
–952
142
Yusuf
S
, Collins R, MacMahon S, Peto R. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials.
Lancet
 .
1988
;
1
:
1088
–1092
143
Antman
EM
, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction.
JAMA
 .
1992
;
268
:
240
–248
144
Teo
KK
, Yusuf S. Role of magnesium in reducing mortality in acute myocardial infarction. A review of the evidence.
Drugs
 .
1993
;
46
:
347
–359
145
Woods
KL
, Fletcher S. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2).
Lancet
 .
1994
;
343
:
816
–819
146
Antman
EM
. Randomized trials of magnesium in acute myocardial infarction: big numbers do not tell the whole story.
Am J Cardiol
 .
1995
;
75
:
391
–393
147
Lancet
 .
1986
;
1
:
397
–402
148
Wilcox
RG
, von der LG, Olsson CG, Jensen G, Skene AM, Hampton JR. Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early Thrombolysis.
Lancet
 .
1990
;
335
:
1175
–1178
149
N Engl J Med
 .
1986
;
314
:
1465
–1471
150
Lancet
 .
1990
;
335
:
427
–431
151
Lancet
 .
1990
;
336
:
71
–75
152
Lancet
 .
1992
;
339
:
753
–770
153
N Engl J Med
 .
1993
;
329
:
673
–682
154
Cannon
CP
, McCabe CH, Diver DJ. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
J Am Coll Cardiol
 .
1994
;
24
:
1602
–1610
155
Granger
CB
, Califf RM, Topol EJ. Thrombolytic therapy for acute myocardial infarction. A review.
Drugs
 .
1992
;
44
:
293
–325
156
BMJ
 .
1994
;
308
:
81
–106
157
Hass
WK
, Easton JD, Adams HP. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients.
N Engl J Med
 .
1989
;
321
:
501
–507
158
Lancet
 .
1994
;
343
:
499
–503
159
Smith
P
, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction.
N Engl J Med
 .
1990
;
323
:
147
–152
160
N Engl J Med
 .
1982
;
307
:
701
–708
161
Yusuf
S
, Zucker D, Peduzzi P. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.
Lancet
 .
1994
;
344
:
563
–570
162
Lancet
 .
1999
;
354
:
708
–715
163
Wallentin
L
, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularization during Instability in Coronary artery disease.
Lancet
 .
2000
;
356
:
9
–16
164
Jeremy
RW
, Hackworthy RA, Bautovich G, Hutton BF, Harris PJ. Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction.
J Am Coll Cardiol
 .
1987
;
9
:
989
–995
165
Pizzetti
G
, Belotti G, Margonato A, Cappelletti A, Chierchia SL. Coronary recanalization by elective angioplasty prevents ventricular dilation after anterior myocardial infarction.
J Am Coll Cardiol
 .
1996
;
28
:
837
–845
166
Eur Heart J
 .
2000
;
21
:
1502
–1513
167
Topol
EJ
, Ferguson JJ, Weisman HF. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention.
JAMA
 .
1997
;
278
:
479
–484
168
Tiefenbrunn
AJ
, Chandra NC, French WJ, Gore JM, Rogers WJ. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2).
J Am Coll Cardiol
 .
1998
;
31
:
1240
–1245
169
Stone
GW
, Brodie BR, Griffin JJ. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial.
J Am Coll Cardiol
 .
1998
;
31
:
23
–30
170
Maillard
L
, Hamon M, Khalife K. A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction.
J Am Coll Cardiol
 .
2000
;
35
:
1729
–1736
171
Grines
CL
, Cox DA, Stone GW. Coronary angioplasty with or without stent implantation for acute myocardial infarction.
N Engl J Med
 .
1999
;
341
:
1949
–1956
172
Brener
SJ
, Barr LA, Burchenal JE. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction.
Circulation
 .
1998
;
98
:
734
–741
173
Neumann
FJ
, Blasini R, Schmitt C. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction.
Circulation
 .
1998
;
98
:
2695
–2701
174
Schomig
A
, Kastrati A, Dirschinger J. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction.
N Engl J Med
 .
2000
;
343
:
385
–391
175
O'Rourke
RA
. Role of myocardial revascularization in sudden cardiac death.
Circulation
 .
1992
;
85
:
I112
–I117
176
Daoud
EG
, Niebauer M, Kou WH. Incidence of implantable defibrillator discharges after coronary revascularization in survivors of ischemic sudden cardiac death.
Am Heart J
 .
1995
;
130
:
277
–280
177
Packer
M
, Carver JR, Rodeheffer RJ. Effect of oral milrinone on mortality in severe chronic heart failure.
N Engl J Med
 .
1991
;
325
:
1468
–1475
178
N Engl J Med
 .
1997
;
336
:
525
–533
179
Circulation
 .
1991
;
84
:
1831
–1851
180
N Engl J Med
 .
1989
;
321
:
406
–412
181
MacMahon
S
, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials.
JAMA
 .
1988
;
260
:
1910
–1916
182
Teo
KK
, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials.
JAMA
 .
1993
;
270
:
1589
–1595
183
Yusuf
S
, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials.
Prog Cardiovasc Dis
 .
1985
;
27
:
335
–371
184
Lancet
 .
2001
;
357
:
1385
–1390
185
Heidenreich
PA
, Lee TT, Massie BM. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials.
J Am Coll Cardiol
 .
1997
;
30
:
27
–34
186
Lancet
 .
1999
;
353
:
9
–13
187
Lancet
 .
1997
;
350
:
1417
–1424
188
Waldo
AL
, Camm AJ, deRuyter H. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction.
Lancet
 .
1996
;
348
:
7
–12
189
Torp-Pedersen
C
, Moller M, Bloch-Thomsen PE. Dofetilide in patients with congestive heart failure and left ventricular dysfunction.
N Engl J Med
 .
1999
;
341
:
857
–865
190
Kober
L
, Thomsen PE, Moller M. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomized trial.
Lancet
 .
2000
;
356
:
2052
–2058
191
N Engl J Med
 .
1992
;
327
:
227
–233
192
Echt
DS
, Liebson PR, Mitchell LB. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
N Engl J Med
 .
1991
;
324
:
781
–788
193
Furberg
CD
, Hawkins CM, Lichstein E. Effect of propranolol in postinfarction patients with mechanical or electrical complications.
Circulation
 .
1984
;
69
:
761
–765
194
Goldman
L
, Sia ST, Cook EF, Rutherford JD, Weinstein MC. Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction.
N Engl J Med
 .
1988
;
319
:
152
–157
195
Nuttal
SL
, Toescu V, Kendall MJ. Beta-blockade after myocardial infarction.
BMJ
 .
2000
;
320
:
581
196
Freemantle
N
, Cleland JG, Young P, Mason J, Harrison J. Beta-blockade after myocardial infarction: systematic review and meta regression analysis.
BMJ
 .
2001
;
318
:
1730
–1737
197
Packer
M
, Bristow MR, Cohn JN. The effect of Cavedilol on morbidity and mortality in patients with chronic heart failure.
N Engl J Med
 .
1996
;
334
:
1349
–1355
198
Krum
H
. Beta-blockers in heart failure.
Drugs
 .
1999
;
58
:
203
–210
199
Eur Heart J
 .
1988
;
9
:
8
–16
200
Cohn
JN
, Fowler MB, Bristow MR. Safety and efficacy of carvedilol in severe heart failure.
J Card Fail
 .
1997
;
3
:
173
–179
201
Held
P
. Effects of beta blockers on ventricular dysfunction after myocardial infarction: tolerability and survival effects.
Am J Cardiol
 .
1993
;
71
:
39C
–44C
202
Kendall
MJ
, Lynch KP, Hjalmarson A, Kjekshus J. Beta-blockers and sudden cardiac death.
Ann Intern Med
 .
1995
;
123
:
358
–367
203
Gottlieb
SS
, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction.
N Engl J Med
 .
1998
;
339
:
489
–497
204
Kennedy
HL
, Rosenson RS. Physician use of beta-adrenergic blocking therapy: a changing perspective.
J Am Coll Cardiol
 .
1995
;
26
:
547
–552
205
Soumerai
SB
, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction.
JAMA
 .
1997
;
277
:
115
–121
206
Podrid
PJ
. Amiodarone: reevaluation of an old drug.
Ann Intern Med
 .
1995
;
122
:
689
–700
207
Julian
DG
, Camm AJ, Frangin G. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
Lancet
 .
1997
;
349
:
667
–674
208
Cairns
JA
, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
Lancet
 .
1997
;
349
:
675
–682
209
Elizari
MV
, Martinez JM, Belziti C. Morbidity and mortality following early administration of amiodarone in acute myocardial infarction.
Eur Heart J
 .
2000
;
21
:
198
–205
210
Ceremuzynski
L
, Kleczar E, Krzeminska-Pakula M. Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study.
J Am Coll Cardiol
 .
1992
;
20
:
1056
–1062
211
Burkart
F
, Pfisterer M, Kiowski W, Follath F, Burckhardt D. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS).
J Am Coll Cardiol
 .
1990
;
16
:
1711
–1718
212
Singh
SN
, Fletcher RD, Fisher SG. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
N Engl J Med
 .
1995
;
333
:
77
–82
213
Doval
HC
, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure.
Lancet
 .
1994
;
344
:
493
–498
214
Garguichevich
JJ
, Ramos JL, Gambarte A. Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA).
Am Heart J
 .
1995
;
130
:
494
–500
215
Hamer
AW
, Arkles LB, Johns JA. Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial.
J Am Coll Cardiol
 .
1989
;
14
:
1768
–1774
216
Janse
MJ
, Malik M, Camm AJ, Julian DG, Frangin GA, Schwartz PJ. Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial).
Eur Heart J
 .
1998
;
19
:
85
–95
217
Mason
JW
. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias.
N Engl J Med
 .
1993
;
329
:
452
–458
218
Haverkamp
W
, Martinez-Rubio A, Hief C. Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest.
J Am Coll Cardiol
 .
1997
;
30
:
487
–495
219
Held
PH
, Yusuf S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.
BMJ
 .
1989
;
299
:
1187
–1192
220
Am J Cardiol
 .
1990
;
66
:
779
–785
221
Waters
D
, Lesperance J, Francetich M. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis.
Circulation
 .
1990
;
82
:
1940
–1953
222
Yusuf
S
, Held P, Furberg C. Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies.
Am J Cardiol
 .
1991
;
67
:
1295
–1297
223
Mirowski
M
, Reid PR, Mower MM. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings.
N Engl J Med
 .
1980
;
303
:
322
–324
224
Fogoros
RN
, Fiedler SB, Elson JJ. The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias.
Ann Intern Med
 .
1987
;
107
:
635
–641
225
Winkle
RA
, Mead RH, Ruder MA. Long-term outcome with the automatic implantable cardioverter–defibrillator.
J Am Coll Cardiol
 .
1989
;
13
:
1353
–1361
226
Fogoros
RN
, Elson JJ, Bonnet CA, Fiedler SB, Burkholder JA. Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease.
J Am Coll Cardiol
 .
1990
;
16
:
381
–386
227
Levine
JH
, Mellits ED, Baumgardner RA. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators.
Circulation
 .
1991
;
84
:
558
–566
228
de Marchena
E
, Chakko S, Fernandez P. Usefulness of the automatic implantable cardioverter defibrillator in improving survival of patients with severely depressed left ventricular function associated with coronary artery disease.
Am J Cardiol
 .
1991
;
67
:
812
–816
229
Newman
D
, Sauve MJ, Herre J. Survival after implantation of the cardioverter defibrillator.
Am J Cardiol
 .
1992
;
69
:
899
–903
230
Bardy
GH
, Hofer B, Johnson G. Implantable transvenous cardioverter-defibrillators.
Circulation
 .
1993
;
87
:
1152
–1168
231
Moss
AJ
, Hall WJ, Cannom DS. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia.
N Engl J Med
 .
1996
;
335
:
1933
–1940
232
Bigger
JT
Jr
. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery.
N Engl J Med
 .
1997
;
337
:
1569
–1575
233
Denes
P
, Gillis AM, Pawitan Y, Kammerling JM, Wilhelmsen L, Salerno DM. Prevalence, characteristics and significance of ventricular premature complexes and ventricular tachycardia detected by 24-hour continuous electrocardiographic recording in the Cardiac Arrhythmia Suppression Trial.
Am J Cardiol
 .
1991
;
68
:
887
–896
234
Buxton
AE
, Marchlinski FE, Flores BT, Miller JM, Doherty JU, Josephson ME. Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study.
Circulation
 .
1987
;
75
:
1178
–1185
235
Wilber
DJ
, Olshansky B, Moran JF, Scanlon PJ. Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function.
Circulation
 .
1990
;
82
:
350
–358
236
Kleiger
RE
, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.
Am J Cardiol
 .
1987
;
59
:
256
–262
237
La Rovere
MT
, Specchia G, Mortara A, Schwartz PJ. Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study.
Circulation
 .
1988
;
78
:
816
–824
238
Bocker
D
, Haverkamp W, Block M, Borggrefe M, Hammel D, Breithardt G. Comparison of d,l-sotalol and implantable defibrillators for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease.
Circulation
 .
1996
;
94
:
151
–157
239
Am J Cardiol
 .
1993
;
72
:
280
–287
240
N Engl J Med
 .
1997
;
337
:
1576
–1583
241
Connolly
SJ
, Gent M, Roberts RS. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.
Circulation
 .
2000
;
101
:
1297
–1302
242
Kuck
KH
, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).
Circulation
 .
2000
;
102
:
748
–754
243
Connolly
SJ
, Hallstrom AP, Cappato R. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials.
Eur Heart J
 .
2000
;
21
:
2071
–2078
244
Morady
F
, Harvey M, Kalbfleisch SJ, el Atassi R, Calkins H, Langberg JJ. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease.
Circulation
 .
1993
;
87
:
363
–372
245
Stevenson
WG
, Khan H, Sager P. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction.
Circulation
 .
1993
;
88
:
1647
–1670
246
van Hemel
NM
, Kingma JH, Defauw JA. Left ventricular segmental wall motion score as a criterion for selecting patients for direct surgery in the treatment of postinfarction ventricular tachycardia.
Eur Heart J
 .
1989
;
10
:
304
–315
247
van Hemel
NM
, Kingma JH, Defauw JJ. Continuation of antiarrhythmic drugs, or arrhythmia surgery after multiple drug failures. A randomized trial in the treatment of postinfarction ventricular tachycardia.
Eur Heart J
 .
1996
;
17
:
564
–573
248
Murgatroyd
F
, Klein GJ, Krahn AD, Yee R, Roberts R. Undocumented syncope with inducible ventricular tachycardia is as malignant as documented symptomatic ventricular tachycardia/fibrilltion. A Canadian Implantable Defibrillator Study (CIDS) subgroup analysis (Abstr).
Circulation
 .
1998
;
98
:
495
249
Raitt
MH
, Renfroe EG, Epstein AE. ‘Stable’ ventricular tachycardia is not a benign rhythm: insights from the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry.
Circulation
 .
2001
;
103
:
244
–252
250
Domanski
MJ
, Sakseena S, Epstein AE. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias.
J Am Coll Cardiol
 .
1999
;
34
:
1090
–1095
251
Sheldon
R
, Connolly S, Krahn A, Roberts R, Gent M, Gardner M. Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study.
Circulation
 .
2000
;
101
:
1660
–1664
252
Moss
AJ
. Implantable cardioverter defibrillator therapy: the sickest patients benefit the most.
Circulation
 .
2000
;
101
:
1638
–1640
253
Spirito
P
, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy.
N Engl J Med
 .
1997
;
336
:
775
–785
254
Maron
BJ
, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.
Circulation
 .
1995
;
92
:
785
–789
255
Maron
BJ
, Peterson EE, Maron MS, Peterson JE. Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study.
Am J Cardiol
 .
1994
;
73
:
577
–580
256
Maron
BJ
. Hypertrophic cardiomyopathy.
Lancet
 .
1997
;
350
:
127
–133
257
Wigle
ED
, Sasson Z, Henderson MA. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review.
Prog Cardiovasc Dis
 .
1985
;
28
:
1
–83
258
Spirito
P
, Maron BJ, Bonow RO, Epstein SE. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy.
Am J Cardiol
 .
1987
;
60
:
123
–129
259
McKenna
W
, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and haemodynamic features.
Am J Cardiol
 .
1981
;
47
:
532
–538
260
McKenna
WJ
, Franklin RC, Nihoyannopoulos P, Robinson KC, Deanfield JE. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy.
J Am Coll Cardiol
 .
1988
;
11
:
147
–153
261
McKenna
WJ
, Deanfield JE. Hypertrophic cardiomyopathy: an important cause of sudden death.
Arch Dis Child
 .
1984
;
59
:
971
–975
262
Spirito
P
, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population.
N Engl J Med
 .
1989
;
320
:
749
–755
263
Maron
BJ
, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.
JAMA
 .
1999
;
281
:
650
–655
264
Cecchi
F
, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.
J Am Coll Cardiol
 .
1995
;
26
:
1529
–1536
265
Maron
BJ
, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles.
JAMA
 .
1996
;
276
:
199
–204
266
Stafford
WJ
, Trohman RG, Bilsker M, Zaman L, Castellanos A, Myerburg RJ. Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy.
J Am Coll Cardiol
 .
1986
;
7
:
701
–704
267
Maron
BJ
, Spirito P. Implications of left ventricular remodeling in hypertrophic cardiomyopathy.
Am J Cardiol
 .
1998
;
81
:
1339
–1344
268
Redwood
CS
, Moolman-Smook JC, Watkins H. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy.
Cardiovasc Res
 .
1999
;
44
:
20
–36
269
Watkins
H
, McKenna WJ, Thierfelder L. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy.
N Engl J Med
 .
1995
;
332
:
1058
–1064
270
Sharma
S
, Elliott P, Whyte G. Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy.
Am J Cardiol
 .
2000
;
86
:
162
–168
271
Maron
BJ
, Roberts WC, Epstein SE. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients.
Circulation
 .
1982
;
65
:
1388
–1394
272
Spirito
P
, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.
N Engl J Med
 .
2000
;
342
:
1778
–1785
273
Elliott
P
, Gimeno Blanes JR, Mahon NG, Poloniecki J, McKenna WJ. Relation between severity of left ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy.
Lancet
 .
2001
;:
274
Elliott
PM
, Poloniecki J, Dickie S. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.
J Am Coll Cardiol
 .
2000
;
36
:
2212
–2218
275
Varnava
A
, Baboonian C, Davison F. A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy.
Heart
 .
1999
;
82
:
621
–624
276
Frenneaux
MP
, Counihan PJ, Caforio AL, Chikamori T, McKenna WJ. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy.
Circulation
 .
1990
;
82
:
1995
–2002
277
Sadoul
N
, Prasad K, Elliott PM, Bannerjee S, Frenneaux MP, McKenna WJ. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy.
Circulation
 .
1997
;
96
:
2987
–2991
278
Counihan
PJ
, Frenneaux MP, Webb DJ, McKenna WJ. Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy.
Circulation
 .
1991
;
84
:
686
–696
279
Olivotto
I
, Maron BJ, Montereggi A, Mazzuoli F, Dolara A, Cecchi F. Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy.
J Am Coll Cardiol
 .
1999
;
33
:
2044
–2051
280
McKenna
WJ
, England D, Doi YL, Deanfield JE, Oakley C, Goodwin JF. Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis.
Br Heart J
 .
1981
;
46
:
168
–172
281
Maron
BJ
, Savage DD, Wolfson JK, Epstein SE. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study.
Am J Cardiol
 .
1981
;
48
:
252
–257
282
Spirito
P
, Rapezzi C, Autore C. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia.
Circulation
 .
1994
;
90
:
2743
–2747
283
McKenna
WJ
, Sadoul N, Slade AK, Saumarez RC. The prognostic significance of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy.
Circulation
 .
1994
;
90
:
3115
–3117
284
Fananapazir
L
, Chang AC, Epstein SE, McAreavey D. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, haemodynamic, and electrophysiological findings.
Circulation
 .
1992
;
86
:
730
–740
285
Cecchi
F
, Maron BJ, Epstein SE. Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest.
J Am Coll Cardiol
 .
1989
;
13
:
1283
–1288
286
Elliott
PM
, Sharma S, Varnava A, Poloniecki J, Rowland E, McKenna WJ. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
J Am Coll Cardiol
 .
1999
;
33
:
1596
–1601
287
Maron
BJ
, Shen WK, Link MS. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
N Engl J Med
 .
2000
;
342
:
365
–373
288
Kuck
KH
, Kunze KP, Schluter M, Nienaber CA, Costard A. Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope.
Eur Heart J
 .
1988
;
9
:
177
–185
289
Saumarez
RC
, Slade AK, Grace AA, Sadoul N, Camm AJ, McKenna WJ. The significance of paced electrogram fractionation in hypertrophic cardiomyopathy. A prospective study.
Circulation
 .
1995
;
91
:
2762
–2768
290
Dilsizian
V
, Bonow RO, Epstein SE, Fananapazir L. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy.
J Am Coll Cardiol
 .
1993
;
22
:
796
–804
291
Maron
BJ
, Leyhe MJ, Casey SA. Assessment of QT dispersion as a prognostic marker for sudden death in a regional nonreferred hypertrophic cardiomyopathy cohort.
Am J Cardiol
 .
2001
;
87
:
114
–115
292
Fei
L
, Slade AK, Grace AA, Malik M, Camm AJ, McKenna WJ. Ambulatory assessment of the QT interval in patients with hypertrophic cardiomyopathy: risk stratification and effect of low dose amiodarone.
Pacing Clin Electrophysiol
 .
1994
;
17
:
2222
–2227
293
McKenna
WJ
, Oakley CM, Krikler DM, Goodwin JF. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
Br Heart J
 .
1985
;
53
:
412
–416
294
Cecchi
F
, Olivotto I, Montereggi A, Squillatini G, Dolara A, Maron BJ. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.
Heart
 .
1998
;
79
:
331
–336
295
Maron
BJ
, Olivotto I, Spirito P. Epidemiology of hypertrophic cardiomyopathy-related death; revisited in a large non-referral-based patients population.
Circulation
 .
2000
;
102
:
858
–864
296
Marcus
FI
, Fontaine GH, Guiraudon G. Right ventricular dysplasia: a report of 24 adult cases.
Circulation
 .
1982
;
65
:
384
–398
297
Richardson
P
, McKenna W, Bristow M. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies [news].
Circulation
 .
1996
;
93
:
841
–842
298
McKenna
WJ
, Thiene G, Nava A. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.
Br Heart J
 .
1994
;
71
:
215
–218
299
Shen
WK
, Edwards WD, Hammill SC, Bailey KR, Ballard DJ, Gersh BJ. Sudden unexpected nontraumatic death in 54 young adults: a 30-year population-based study.
Am J Cardiol
 .
1995
;
76
:
148
–152
300
Goodin
JC
, Farb A, Smialek JE, Field F, Virmani R. Right ventricular dysplasia associated with sudden death in young adults.
Mod Pathol
 .
1991
;
4
:
702
–706
301
Corrado
D
, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes.
N Engl J Med
 .
1998
;
339
:
364
–369
302
Tabib
A
, Miras A, Taniere P, Loire R. Undetected cardiac lesions cause unexpected sudden cardiac death during occasional sport activity. A report of 80 cases.
Eur Heart J
 .
1999
;
20
:
900
–903
303
Rampazzo
A
, Nava A, Danieli GA. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24.
Hum Mol Genet
 .
1994
;
3
:
959
–962
304
McKoy
G
, Protonotarios N, Crosby A. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease).
Lancet
 .
2000
;
355
:
2119
–2124
305
Jaoude
SA
, Leclercq JF, Coumel P. Progressive ECG changes in arrhythmogenic right ventricular disease. Evidence for an evolving disease.
Eur Heart J
 .
1996
;
17
:
1717
–1722
306
Daliento
L
, Turrini P, Nava A. Arrhythmogenic right ventricular cardiomyopathy in young versus adult patients: similarities and differences.
J Am Coll Cardiol
 .
1995
;
25
:
655
–664
307
Berder
V
, Vauthier M, Mabo P. Characteristics and outcome in arrhythmogenic right ventricular dysplasia.
Am J Cardiol
 .
1995
;
75
:
411
–414
308
Peters
S
. Right ventricular cardiomyopathy: diffuse dilatation, focal dysplasia or biventricular disease.
Int J Cardiol
 .
1997
;
62
:
63
–67
309
Blomstrom-Lundqvist
C
, Sabel KG, Olsson SB. A long term follow up of 15 patients with arrhythmogenic right ventricular dysplasia.
Br Heart J
 .
1987
;
58
:
477
–488
310
Marcus
FI
, Fontaine GH, Frank R, Gallagher JJ, Reiter MJ. Long-term follow-up in patients with arrhythmogenic right ventricular disease.
Eur Heart J
 .
1989
;
10
:
68
–73
311
Corrado
D
, Basso C, Thiene G. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study.
J Am Coll Cardiol
 .
1997
;
30
:
1512
–1520
312
Nava
A
, Thiene G, Canciani B. Familial occurrence of right ventricular dysplasia: a study involving nine families.
J Am Coll Cardiol
 .
1988
;
12
:
1222
–1228
313
Benn
M
, Hansen PS, Pedersen AK. QT dispersion in patients with arrhythmogenic right ventricular dysplasia.
Eur Heart J
 .
1999
;
20
:
764
–770
314
De Ambroggi
L
, Aime E, Ceriotti C, Rovida M, Negroni S. Mapping of ventricular repolarization potentials in patients with arrhythmogenic right ventricular dysplasia: principal component analysis of the ST-T waves.
Circulation
 .
1997
;
96
:
4314
–4318
315
Turrini
P
, Angelini A, Thiene G. Late potentials and ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
Am J Cardiol
 .
1999
;
83
:
1214
–1219
316
Leclercq
JF
, Coumel P. Late potentials in arrhythmogenic right ventricular dysplasia. Prevalence, diagnostic and prognostic values.
Eur Heart J
 .
1993
;
14
:
80
–83
317
Mehta
D
, Goldman M, David O, Gomes JA. Value of quantitative measurement of signal-averaged electrocardiographic variables in arrhythmogenic right ventricular dysplasia: correlation with echocardiographic right ventricular cavity dimensions.
J Am Coll Cardiol
 .
1996
;
28
:
713
–719
318
Hermida
JS
, Minassian A, Jarry G. Familial incidence of late ventricular potentials and electrocardiographic abnormalities in arrhythmogenic right ventricular dysplasia.
Am J Cardiol
 .
1997
;
79
:
1375
–1380
319
Wichter
T
, Borggrefe M, Haverkamp W, Chen X, Breithardt G. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia.
Circulation
 .
1992
;
86
:
29
–37
320
Lemery
R
, Brugada P, Janssen J, Cheriex E, Dugernier T, Wellens HJ. Nonischemic sustained ventricular tachycardia: clinical outcome in 12 patients with arrhythmogenic right ventricular dysplasia.
J Am Coll Cardiol
 .
1989
;
14
:
96
–105
321
Peters
S
. Left ventricular impairment in arrhythmogenic right ventricular dysplasia: what we can learn from angiography.
Cardiology
 .
1995
;
86
:
473
–476
322
Thiene
G
, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people.
N Engl J Med
 .
1988
;
318
:
129
–133
323
Corrado
D
, Thiene G, Nava A, Rossi L, Pennelli N. Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases.
Am J Med
 .
1990
;
89
:
588
–596
324
Leclercq
JF
, Coumel P. Characteristics, prognosis and treatment of the ventricular arrhythmias of right ventricular dysplasia.
Eur Heart J
 .
1989
;
10
:
61
–67
325
Leclercq
JF
, Potenza S, Maison-Blanche P, Chastang C, Coumel P. Determinants of spontaneous occurrence of sustained monomorphic ventricular tachycardia in right ventricular dysplasia.
J Am Coll Cardiol
 .
1996
;
28
:
720
–724
326
Fornes
P
, Ratel S, Lecomte D. Pathology of arrhythmogenic right ventricular cardiomyopathy/dysplasia—an autopsy study of 20 forensic cases.
J Forensic Sci
 .
1998
;
43
:
777
–783
327
Furlanello
F
, Bertoldi A, Dallago M. Cardiac arrest and sudden death in competitive athletes with arrhythmogenic right ventricular dysplasia.
Pacing Clin Electrophysiol
 .
1998
;
21
:
331
–335
328
Harada
T
, Aonuma K, Yamauchi Y. Catheter ablation of ventricular tachycardia in patients with right ventricular dysplasia: Identification of target sites by entrainment mapping techniques.
Pacing Clin Electrophysiol
 .
1998
;
21
:
2547
–2550
329
Ellison
KE
, Friedman PL, Ganz LI, Stevenson WG. Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia.
J Am Coll Cardiol
 .
1998
;
32
:
724
–728
330
Link
MS
, Wang PJ, Haugh CJ. Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillators.
J Interv Card Electrophysiol
 .
1997
;
1
:
41
–48
331
Breithardt
G
, Wichter T, Haverkamp W. Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease.
Am Heart J
 .
1994
;
127
:
1151
–1158
332
Codd
MB
, Sugrue DD, Gersh BJ, Melton LJ. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975–1984.
Circulation
 .
1989
;
80
:
564
–572
333
Michels
VV
, Moll PP, Miller FA. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy.
N Engl J Med
 .
1992
;
326
:
77
–82
334
Keeling
PJ
, Gang Y, Smith G. Familial dilated cardiomyopathy in the United Kingdom.
Br Heart J
 .
1995
;
73
:
417
–421
335
Fuster
V
, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathy.
Am J Cardiol
 .
1981
;
47
:
525
–531
336
Di Lenarda
A
, Secoli G, Perkan A. Changing mortality in dilated cardiomyopathy.
Br Heart J
 .
1994
;
72
:
S46
–S51
337
Dec
GW
, Fuster V. Idiopathic dilated cardiomyopathy.
N Engl J Med
 .
1994
;
331
:
1564
–1575
338
Kelly
P
, Coats A. Variation in mode of sudden cardiac death in patients with dilated cardiomyopathy.
Eur Heart J
 .
1997
;
18
:
879
–880
339
Tamburro
P
, Wilber D. Sudden death in idiopathic dilated cardiomyopathy.
Am Heart J
 .
1992
;
124
:
1035
–1045
340
Stewart
RA
, McKenna WJ, Oakley CM. Good prognosis for dilated cardiomyopathy without severe heart failure or arrhythmia.
Q J Med
 .
1990
;
74
:
309
–318
341
Hofmann
T
, Meinertz T, Kasper W. Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants.
Am Heart J
 .
1988
;
116
:
1455
–1463
342
Romeo
F
, Pelliccia F, Cianfrocca C, Cristofani R, Reale A. Predictors of sudden death in idiopathic dilated cardiomyopathy.
Am J Cardiol
 .
1989
;
63
:
138
–140
343
Gradman
A
, Deedwania P, Cody R. Predictors of total mortality and sudden death in mild to moderate heart failure.
J Am Coll Cardiol
 .
1989
;
14
:
564
–570
344
Keogh
AM
, Baron DW, Hickie JB. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation.
Am J Cardiol
 .
1990
;
65
:
903
–908
345
Brembilla-Perrot
B
, Donetti J, de la Chaise AT, Sadoul N, Aliot E, Juilliere Y. Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy.
Am Heart J
 .
1991
;
121
:
1124
–1131
346
Middlekauff
HR
, Stevenson WG, Stevenson LW, Saxon LA. Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope.
J Am Coll Cardiol
 .
1993
;
21
:
110
–116
347
Knight
BP
, Goyal R, Pelosi F. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator.
J Am Coll Cardiol
 .
1999
;
33
:
1964
–1970
348
Kron
J
, Hart M, Schual-Berke S, Niles NR, Hosenpud JD, McAnulty JH. Idiopathic dilated cardiomyopathy. Role of programmed electrical stimulation and Holter monitoring in predicting those at risk of sudden death.
Chest
 .
1988
;
93
:
85
–90
349
Meinertz
T
, Hofmann T, Kasper W. Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy.
Am J Cardiol
 .
1984
;
53
:
902
–907
350
Wilber
DJ
. Evaluation and treatment of nonsustained ventricular tachycardia.
Curr Opin Cardiol
 .
1996
;
11
:
23
–31
351
Galinier
M
, Bounhoure JP. Treatment of cardiac insufficiency: does treatment depend on whether its cause is ischemic or idiopathic?
Arch Mal Coeur Vaiss
 .
1999
;
92
:
727
–732
352
Steinberg
J
, Ehlert F, Cannon D. Dilated cardiomyopathy versus coronary artery disease in patients with VT/VF: differences in presentation and outcome in the arrhythmics versus implantable defibrillators (AVID) registry (Abstr).
Circulation
 .
1997
;
96
:
15
353
Schwartz
PJ
, Priori SG, Napolitano C. The Long QT Syndrome. Zipes DP, Jalife J. Cardiac Electrophysiology. From Cell to Bedside. Philadelphia: WB Saunders Co; 2000. p. 597–615
354
Priori
SG
, Barhanin J, Hauer RN. Genetic and molecular basis of cardiac arrhythmias; impact on clinical management.
Eur Heart J
 .
1999
;
20
:
174
–195
355
Priori
SG
, Barhanin J, Hauer RN. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part III.
Circulation
 .
1999
;
99
:
674
–681
356
Priori
SG
, Barhanin J, Hauer RN. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II.
Circulation
 .
1999
;
99
:
518
–528
357
Locati
EH
, Zareba W, Moss AJ. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry.
Circulation
 .
1998
;
97
:
2237
–2244
358
Moss
AJ
, Zareba W, Hall WJ. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome.
Circulation
 .
2000
;
101
:
616
–623
359
Priori
SG
, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact.
Circulation
 .
1999
;
99
:
529
–533
360
Moss
AJ
, Schwartz PJ, Crampton RS. The long QT syndrome. Prospective longitudinal study of 328 families.
Circulation
 .
1991
;
84
:
1136
–1144
361
Priori
SG
, Napolitano C, Diehl L, Schwartz PJ. Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome.
Circulation
 .
1994
;
89
:
1681
–1689
362
Schwartz
PJ
, Malliani A. Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome.
Am Heart J
 .
1975
;
89
:
45
–50
363
Zareba
W
, Moss AJ, le Cessie S, Hall WJ. T wave alternans in idiopathic long QT syndrome.
J Am Coll Cardiol
 .
1994
;
23
:
1541
–1546
364
Rashba
EJ
, Zareba W, Moss AJ. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome.
Circulation
 .
1998
;
97
:
451
–456
365
Zareba
W
, Moss AJ, Schwartz PJ. Influence of genotype on the clinical course of the long-QT syndrome.
N Engl J Med
 .
1998
;
339
:
960
–965
366
Schwartz
PJ
, Priori SG, Spazzolini C. Genotype-phenotype correlation in the long-QT syndrome:gene-specific triggers for life-threatening arrhythmias.
Circulation (Online)
 .
2001
;
103
:
89
–95
367
Marks
ML
, Trippel DL, Keating MT. Long QT syndrome associated with syndactyly identified in females.
Am J Cardiol
 .
1995
;
76
:
744
–745
368
Bhandari
AK
, Shapiro WA, Morady F, Shen EN, Mason J, Scheinman MM. Electrophysiologic testing in patients with the long QT syndrome.
Circulation
 .
1985
;
71
:
63
–71
369
Napolitano
C
, Schwartz PJ, Brown AM. Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias.
J Cardiovasc Electrophysiol
 .
2000
;
11
:
691
–696
370
Schwartz
PJ
. Idiopathic long QT syndrome: progress and questions.
Am Heart J
 .
1985
;
109
:
399
–411
371
Schwartz
PJ
, Locati EH, Moss AJ, Crampton RS, Trazzi R, Ruberti U. Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. A worldwide report.
Circulation
 .
1991
;
84
:
503
–511
372
Moss
AJ
, Liu JE, Gottlieb S, Locati EH, Schwartz PJ, Robinson JL. Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome.
Circulation
 .
1991
;
84
:
1524
–1529
373
Dorostkar
PC
, Eldar M, Belhassen B, Scheinman MM. Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing.
Circulation
 .
1999
;
100
:
2431
–2436
374
Brugada
P
, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report.
J Am Coll Cardiol
 .
1992
;
20
:
1391
–1396
375
Brugada
J
, Brugada R, Brugada P. Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease.
Circulation
 .
1998
;
97
:
457
–460
376
Priori
SG
, Napolitano C, Gasparini M. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome : A prospective evaluation of 52 families.
Circulation
 .
2000
;
102
:
2509
–2515
377
Dumaine
R
, Towbin JA, Brugada P. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent.
Circ Res
 .
1999
;
85
:
803
–809
378
Brugada
R
, Brugada J, Antzelevitch C. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts.
Circulation
 .
2000
;
101
:
510
–515
379
Coumel
P
, Fidelle J, Lucet V, Attuel P, Bouvrain Y. Catecholaminergic-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases.
Br Heart J
 .
1978
;
40
:
28
–37
380
Leenhardt
A
, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients.
Circulation
 .
1995
;
91
:
1512
–1519
381
de Paola
AA
, Horowitz LN, Marques FB. Control of multiform ventricular tachycardia by propranolol in a child with no identifiable cardiac disease and sudden death.
Am Heart J
 .
1990
;
119
:
1429
–1432
382
Noh
CI
, Gillette PC, Case CL, Zeigler VL. Clinical and electrophysiological characteristics of ventricular tachycardia in children with normal hearts.
Am Heart J
 .
1990
;
120
:
1326
–1333
383
Swan
H
, Piippo K, Viitasalo M. Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts.
J Am Coll Cardiol
 .
1999
;
34
:
2035
–2042
384
Rosen
MR
, Danilo P Jr. Effects of tetrodotoxin, lidocaine, verapamil, and AHR-2666 on Ouabain-induced delayed afterdepolarizations in canine Purkinje fibers.
Circ Res
 .
1980
;
46
:
117
–124
385
Marks
AR
. Cardiac intracellular calcium release channels: role in heart failure.
Circ Res
 .
2000
;
87
:
8
–11
386
Priori
SG
, Napolitano C, Tiso N. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.
Circulation
 .
2001
;
103
:
196
–200
387
Ross
J
Jr
, Braunwald E. Aortic stenosis.
Circulation
 .
1968
;
38
:
61
–67
388
Otto
CM
, Burwash IG, Legget ME. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome.
Circulation
 .
1997
;
95
:
2262
–2270
389
Horstkotte
D
, Loogen F. The natural history of aortic valve stenosis.
Eur Heart J
 .
1988
;
9
:
57
–64
390
Pellikka
PA
, Nishimura RA, Bailey KR, Tajik AJ. The natural history of adults with asymptomatic, haemodynamically significant aortic stenosis.
J Am Coll Cardiol
 .
1990
;
15
:
1012
–1017
391
Lund
O
, Nielsen TT, Emmertsen K. Mortality and worsening of prognostic profile during waiting time for valve replacement in aortic stenosis.
Thorac Cardiovasc Surg
 .
1996
;
44
:
289
–295
392
Olshausen
KV
, Witt T, Pop T, Treese N, Bethge KP, Meyer J. Sudden cardiac death while wearing a Holter monitor.
Am J Cardiol
 .
1991
;
67
:
381
–386
393
Dhingra
RC
, Leon F, Pietras RJ. Sites of conduction disease in aortic stenosis: significance of valve gradient and calcification.
Ann Intern Med
 .
1977
;
87
:
275
–280
394
Darbar
D
, Cherry CJ, Kerins DM. QT dispersion is reduced after valve replacement in patients with aortic stenosis.
Heart
 .
1999
;
82
:
15
–18
395
Sorgato
A
, Faggiano P, Simoncelli U, Rusconi C. Prevalence of late potentials in adult aortic stenosis.
Int J Cardiol
 .
1996
;
53
:
55
–59
396
Ducceschi
V
, Sarubbi B, D'Andrea A. Increased QT dispersion and other repolarization abnormalities as a possible cause of electrical instability in isolated aortic stenosis.
Int J Cardiol
 .
1998
;
64
:
57
–62
397
Martinez-Rubio
A
, Schwammenthal Y, Schwammenthal E. Patients with valvular heart disease presenting with sustained ventricular tachyarrhythmias or syncope: results of programmed ventricular stimulation and long-term follow-up.
Circulation
 .
1997
;
96
:
500
–508
398
Braunwald
E
. Commentary.
Cardiol Rev
 .
1993
;
1
:
349
399
Czer
LS
, Gray RJ, Stewart ME, De Robertis M, Chaux A, Matloff JM. Reduction in sudden late death by concomitant revascularization with aortic valve replacement.
J Thorac Cardiovasc Surg
 .
1988
;
95
:
390
–401
400
Gohlke-Barwolf
C
, Peters K, Petersen J. Influence of aortic valve replacement on sudden death in patients with pure aortic stenosis.
Eur Heart J
 .
1988
;
9
:
139
–141
401
Foppl
M
, Hoffmann A, Amann FW. Sudden cardiac death after aortic valve surgery: incidence and concomitant factors.
Clin Cardiol
 .
1989
;
12
:
202
–207
402
Blackstone
EH
, Kirklin JW. Death and other time-related events after valve replacement.
Circulation
 .
1985
;
72
:
753
–767
403
Keefe
DL
, Griffin JC, Harrison DC, Stinson EB. Atrioventricular conduction abnormalities in patients undergoing isolated aortic or mitral valve replacement.
Pacing Clin Electrophysiol
 .
1985
;
8
:
393
–398
404
Boughaleb
D
, Mansourati J, Genet L, Barra J, Mondine P, Blanc JJ. Permanent cardiac stimulation after aortic valve replacement: incidence, predictive factors and long-term prognosis.
Arch Mal Coeur Vaiss
 .
1994
;
87
:
925
–930
405
Cheitlin
MD
, Alpert JS, Armstrong WF. ACC/AHA Guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in colloboration with the American Society of Echocardiography.
Circulation
 .
1997
;
95
:
1686
–1744
406
Freed
LA
, Levy D, Levine RA. Prevalence and clinical outcome of mitral-valve prolapse.
N Engl J Med
 .
1999
;
341
:
1
–7
407
Curtius
JM
, Bents R, Bungard U. Clinical course of 470 patients with mitral valve prolapse.
Z Kardiol
 .
1986
;
75
:
1
–7
408
Zuppiroli
A
, Rinaldi M, Kramer-Fox R, Favilli S, Roman MJ, Devereux RB. Natural history of mitral valve prolapse.
Am J Cardiol
 .
1995
;
75
:
1028
–1032
409
Vohra
J
, Sathe S, Warren R, Tatoulis J, Hunt D. Malignant ventricular arrhythmias in patients with mitral valve prolapse and mild mitral regurgitation.
Pacing Clin Electrophysiol
 .
1993
;
16
:
387
–393
410
Corrado
D
, Basso C, Nava A, Rossi L, Thiene G. Sudden death in young people with apparently isolated mitral valve prolapse.
G Ital Cardiol
 .
1997
;
27
:
1097
–1105
411
Nishimura
RA
, McGoon MD, Shub C, Miller FA Jr, Ilstrup DM, Tajik AJ. Echocardiographically documented mitral-valve prolapse. Long-term follow-up of 237 patients.
N Engl J Med
 .
1985
;
313
:
1305
–1309
412
Boudoulas
H
, Schaal SF, Stang JM, Fontana ME, Kolibash AJ, Wooley CF. Mitral valve prolapse: cardiac arrest with long-term survival.
Int J Cardiol
 .
1990
;
26
:
37
–44
413
Babuty
D
, Cosnay P, Breuillac JC. Ventricular arrhythmia factors in mitral valve prolapse.
Pacing Clin Electrophysiol
 .
1994
;
17
:
1090
–1099
414
Campbell
RW
, Godman MG, Fiddler GI, Marquis RM, Julian DG. Ventricular arrhythmias in syndrome of balloon deformity of mitral valve. Definition of possible high risk group.
Br Heart J
 .
1976
;
38
:
1053
–1057
415
Tieleman
RG
, Crijns HJ, Wiesfeld AC, Posma J, Hamer HP, Lie KI. Increased dispersion of refractoriness in the absence of QT prolongation in patients with mitral valve prolapse and ventricular arrhythmias.
Br Heart J
 .
1995
;
73
:
37
–40
416
Kulan
K
, Komsuoglu B, Tuncer C, Kulan C. Significance of QT dispersion on ventricular arrhythmias in mitral valve prolapse.
Int J Cardiol
 .
1996
;
54
:
251
–257
417
Savage
DD
, Garrison RJ, Devereux RB. Mitral valve prolapse in the general population. 1. Epidemiologic features: the Framingham Study.
Am Heart J
 .
1983
;
106
:
571
–576
418
Angelini
P
. Normal and anomalous coronary arteries: definitions and classification.
Am Heart J
 .
1989
;
117
:
418
–434
419
Kimbiris
D
, Iskandrian AS, Segal BL, Bemis CE. Anomalous aortic origin of coronary arteries.
Circulation
 .
1978
;
58
:
606
–615
420
Liberthson
RR
, Dinsmore RE, Fallon JT. Aberrant coronary artery origin from the aorta. Report of 18 patients, review of literature and delineation of natural history and management.
Circulation
 .
1979
;
59
:
748
–754
421
Click
RL
, Holmes DR, Vlietstra RE, Kosinski AS, Kronmal RA. Anomalous coronary arteries: location, degree of atherosclerosis and effect on survival—a report from the Coronary Artery Surgery Study.
J Am Coll Cardiol
 .
1989
;
13
:
531
–537
422
Cheitlin
MD
, De Castro CM, McAllister HA. Sudden death as a complication of anomalous left coronary origin from the anterior sinus of Valsalva, A not-so-minor congenital anomaly.
Circulation
 .
1974
;
50
:
780
–787
423
Viskin
S
, Belhassen B, Paredes A, Yakirevich V, Miller H, Laniado S. Anomalous origin of the left coronary artery from the pulmonary artery: report of an adult with ventricular fibrillation as the presenting symptom.
Am Heart J
 .
1992
;
124
:
221
–222
424
Menahem
S
, Venables AW. Anomalous left coronary artery from the pulmonary artery: a 15 year sample.
Br Heart J
 .
1987
;
58
:
378
–384
425
Karr
SS
, Parness IA, Spevak PJ, van der Velde ME, Colan SD, Sanders SP. Diagnosis of anomalous left coronary artery by Doppler color flow mapping: distinction from other causes of dilated cardiomyopathy.
J Am Coll Cardiol
 .
1992
;
19
:
1271
–1275
426
Fernandes
F
, Alam M, Smith S, Khaja F. The role of transesophageal echocardiography in identifying anomalous coronary arteries.
Circulation
 .
1993
;
88
:
2532
–2540
427
Kochman
W
, Dabrowski M, Ruzyllo W. Myocardial bridging as an isolated angiographic change in the anterior descending branch of the left coronary artery.
Kardiol Pol
 .
1990
;
33
:
27
–33
428
Ishii
T
, Hosoda Y, Osaka T. The significance of myocardial bridge upon atherosclerosis in the left anterior descending coronary artery.
J Pathol
 .
1986
;
148
:
279
–291
429
Ge
J
, Jeremias A, Rupp A. New signs characteristic of myocardial bridging demonstrated by intracoronary ultrasound and Doppler.
Eur Heart J
 .
1999
;
20
:
1707
–1716
430
Bestetti
RB
, Costa RS, Zucolotto S, Oliveira JS. Fatal outcome associated with autopsy proven myocardial bridging of the left anterior descending coronary artery.
Eur Heart J
 .
1989
;
10
:
573
–576
431
Desseigne
P
, Tabib A, Loire R. Myocardial bridging on the left anterior descending coronary artery and sudden death. Apropos of 19 cases with autopsy.
Arch Mal Coeur Vaiss
 .
1991
;
84
:
511
–516
432
Cutler
D
, Wallace JM. Myocardial bridging in a young patient with sudden death.
Clin Cardiol
 .
1997
;
20
:
581
–583
433
Tio
RA
, Van Gelder IC, Boonstra PW, Crijns HJ. Myocardial bridging in a survivor of sudden cardiac near-death: role of intracoronary doppler flow measurements and angiography during dobutamine stress in the clinical evaluation.
Heart
 .
1997
;
77
:
280
–282
434
Yetman
AT
, McCrindle BW, MacDonald C, Freedom RM, Gow R. Myocardial bridging in children with hypertrophic cardiomyopathy—a risk factor for sudden death.
N Engl J Med
 .
1998
;
339
:
1201
–1209
435
Schwarz
ER
, Klues HG, Vom DJ, Klein I, Krebs W, Hanrath P. Functional, angiographic and intracoronary Doppler flow characteristics in symptomatic patients with myocardial bridging: effect of short-term intravenous beta-blocker medication.
J Am Coll Cardiol
 .
1996
;
27
:
1637
–1645
436
Stables
RH
, Knight CJ, McNeill JG, Sigwart U. Coronary stenting in the management of myocardial ischaemia caused by muscle bridging.
Br Heart J
 .
1995
;
74
:
90
–92
437
Prasad
VS
, Shivaprakash K, Arumugan SB, Cherian KM. Modified supra-arterial myotomy for intermittent coronary obstruction by myocardial bridges.
Scand J Thorac Cardiovasc Surg
 .
1995
;
29
:
91
–93
438
Timmermans
C
, Smeets JL, Rodriguez LM, Vrouchos G, van den DA, Wellens HJ. Aborted sudden death in the Wolff–Parkinson–White syndrome.
Am J Cardiol
 .
1995
;
76
:
492
–494
439
Munger
TM
, Packer DL, Hammill SC. A population study of the natural history of Wolff–Parkinson–White syndrome in Olmsted County, Minnesota, 1953–1989.
Circulation
 .
1993
;
87
:
866
–873
440
Goudevenos
JA
, Katsouras CS, Graekas G, Argiri O, Giogiakas V, Sideris DA. Ventricular pre-excitation in the general population: a study on the mode of presentation and clinical course.
Heart
 .
2000
;
83
:
29
–34
441
Klein
GJ
, Bashore TM, Sellers TD, Pritchett EL, Smith WM, Gallagher JJ. Ventricular fibrillation in the Wolff–Parkinson–White syndrome.
N Engl J Med
 .
1979
;
301
:
1080
–1085
442
Beckman
KJ
, Gallastegui JL, Bauman JL, Hariman RJ. The predictive value of electrophysiologic studies in untreated patients with Wolff–Parkinson–White syndrome.
J Am Coll Cardiol
 .
1990
;
15
:
640
–647
443
Attoyan
C
, Haissaguerre M, Dartigues JF, Le Metayer P, Warin JF, Clementy J. Ventricular fibrillation in Wolff–Parkinson–White syndrome. Predictive factors.
Arch Mal Coeur Vaiss
 .
1994
;
87
:
889
–897
444
Montoya
PT
, Brugada P, Smeets J. Ventricular fibrillation in the Wolff–Parkinson–White syndrome.
Eur Heart J
 .
1991
;
12
:
144
–150
445
Wellens
HJ
, Bar FW, Gorgels AP, Vanagt EJ. Use of ajmaline in patients with the Wolff–Parkinson–White syndrome to disclose short refractory period of the accessory pathway.
Am J Cardiol
 .
1980
;
45
:
130
–133
446
Auricchio
A
, Klein H, Trappe HJ, Wenzlaff P. Lack of prognostic value of syncope in patients with Wolff–Parkinson–White syndrome.
J Am Coll Cardiol
 .
1991
;
17
:
152
–158
447
Brembilla-Perrot
B
, Ghawi R. Electrophysiological characteristics of asymptomatic Wolff–Parkinson–White syndrome.
Eur Heart J
 .
1993
;
14
:
511
–515
448
Leitch
JW
, Klein GJ, Yee R, Murdock C. Prognostic value of electrophysiology testing in asymptomatic patients with Wolff–Parkinson–White pattern.
Circulation
 .
1990
;
82
:
1718
–1723
449
Zipes
DP
, DiMarco JP, Gillette PC. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology.
J Am Coll Cardiol
 .
1995
;
26
:
555
–573
450
Nikolic
G
, Bishop RL, Singh JB. Sudden death recorded during Holter monitoring.
Circulation
 .
1982
;
66
:
218
–225
451
Schmidinger
H
, Weber H. Sudden death during ambulatory Holter monitoring.
Int J Cardiol
 .
1987
;
16
:
169
–176
452
Feruglio
G
, Rickards A, Steinbach K. Cardiac Pacing in the world: A survey of the state of the art in 1986.
Pacing Clin Electrophysiol
 .
1987
;
10
:
768
–777
453
Shaw
DB
, Holman RR, Gowers JI. Survival in sinoatrial disorder (sick-sinus syndrome).
Br Med J
 .
1980
;
280
:
139
–141
454
Rosenqvist
M
, Brandt J, Schuller H. Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality.
Am Heart J
 .
1988
;
116
:
16
–22
455
Krahn
AD
, Klein GJ, Yee R, Takle-Newhouse T, Norris C. Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators.
Circulation
 .
1999
;
99
:
406
–410
456
Andersen
HR
, Nielsen JC, Thomsen PE. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome.
Lancet
 .
1997
;
350
:
1210
–1216
457
Fisch
GR
, Zipes DP, Fisch C. Bundle branch block and sudden death.
Prog Cardiovasc Dis
 .
1980
;
23
:
187
–224
458
McAnulty
JH
, Rahimtoola SH, Murphy E. Natural history of ‘high-risk’ bundle-branch block: final report of a prospective study.
N Engl J Med
 .
1982
;
307
:
137
–143
459
Dhingra
RC
, Denes P, Wu D, Chuquimia R, Rosen KM. The significance of second degree atrioventricular block and bundle branch block. Observations regarding site and type of block.
Circulation
 .
1974
;
49
:
638
–646
460
Br Heart J
 .
1991
;
66
:
185
–191
461
Shaw
DB
, Kekwick CA, Veale D, Gowers J, Whistance T. Survival in second degree atrioventricular block.
Br Heart J
 .
1985
;
53
:
587
–593
462
Johansson
BW
. Complete heart block. A clinical, haemodynamic and pharmacological study in patients with and without an artificial pacemaker.
Acta Med Scand Suppl
 .
1966
;
451
:
1
–127
463
Strasberg
B
, Amat YL, Dhingra RC. Natural history of chronic second-degree atrioventricular nodal block.
Circulation
 .
1981
;
63
:
1043
–1049
464
Edhag
O
, Swahn A. Prognosis of patients with complete heart block or arrhythmic syncope who were not treated with artificial pacemakers. A long-term follow-up study of 101 patients.
Acta Med Scand
 .
1976
;
200
:
457
–463
465
Hindman
MC
, Wagner GS, JaRo M. The clinical significance of bundle branch block complicating acute myocardial infarction. 2. Indications for temporary and permanent pacemaker insertion.
Circulation
 .
1978
;
58
:
689
–699
466
Denes
P
, Dhingra RC, Wu D, Wyndham CR, Leon F, Rosen KM. Sudden death in patients with chronic bifascicular block.
Arch Intern Med
 .
1977
;
137
:
1005
–1010
467
Dhingra
RC
, Amat YL, Wyndham C, Sridhar SS, Wu D, Rosen KM. Significance of left axis deviation in patients with chronic left bundle branch block.
Am J Cardiol
 .
1978
;
42
:
551
–556
468
Ezri
M
, Lerman BB, Marchlinski FE, Buxton AE, Josephson ME. Electrophysiologic evaluation of syncope in patients with bifascicular block.
Am Heart J
 .
1983
;
106
:
693
–697
469
Morady
F
, Higgins J, Peters RW. Electrophysiologic testing in bundle branch block and unexplained syncope.
Am J Cardiol
 .
1984
;
54
:
587
–591
470
Twidale
N
, Heddle WF, Ayres BF, Tonkin AM. Clinical implications of electrophysiology study findings in patients with chronic bifascicular block and syncope.
Aust N Z J Med
 .
1988
;
18
:
841
–847
471
Dhingra
RC
, Wyndham C, Bauernfeind R. Significance of block distal to the His bundle induced by atrial pacing in patients with chronic bifascicular block.
Circulation
 .
1979
;
60
:
1455
–1464
472
Click
RL
, Gersh BJ, Sugrue DD. Role of invasive electrophysiologic testing in patients with symptomatic bundle branch block.
Am J Cardiol
 .
1987
;
59
:
817
–823
473
Peters
RW
, Scheinman MM, Modin C, O'Young J, Somelofski CA, Mies C. Prophylactic permanent pacemakers for patients with chronic bundle branch block.
Am J Med
 .
1979
;
66
:
978
–985
474
Scheinman
MM
, Peters RW, Suave MJ. Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing.
Am J Cardiol
 .
1982
;
50
:
1316
–1322
475
Scheinman
MM
, Weiss AN, Shafton E, Benowitz N, Rowland M. Electrophysiologic effects of procaine amide in patients with intraventricular conduction delay.
Circulation
 .
1974
;
49
:
522
–529
476
Tonkin
AM
, Heddle WF, Tornos P. Intermittent atrioventricular block: procainamide administration as a provocative test.
Aust N Z J Med
 .
1978
;
8
:
594
–602
477
Clemmensen
P
, Bates ER, Califf RM. Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy.
Am J Cardiol
 .
1991
;
67
:
225
–230
478
Behar
S
, Zissman E, Zion M. Prognostic significance of second-degree atrioventricular block in inferior wall acute myocardial infarction.
Am J Cardiol
 .
1993
;
72
:
831
–834
479
Berger
PB
, Ruocco NA, Ryan TJ, Frederick MM, Jacobs AK, Faxon DP. Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II.
J Am Coll Cardiol
 .
1992
;
20
:
533
–540
480
Col
JJ
, Weinberg SL. The incidence and mortality of intraventricular conduction defects in acute myocardial infarction.
Am J Cardiol
 .
1972
;
29
:
344
–350
481
Ginks
WR
, Sutton R, Oh W, Leatham A. Long-term prognosis after acute anterior infarction with atrioventricular block.
Br Heart J
 .
1977
;
39
:
186
–189
482
Lamas
GA
, Muller JE, Turi ZG. A simplified method to predict occurrence of complete heart block during acute myocardial infarction.
Am J Cardiol
 .
1986
;
57
:
1213
–1219
483
Sholler
GF
, Walsh EP. Congenital complete heart block in patients without anatomic cardiac defects.
Am Heart J
 .
1989
;
118
:
1193
–1198
484
Michaelsson
M
, Jonzon A, Riesenfeld T. Isolated congenital complete atrioventricular block in adult life. A prospective study.
Circulation
 .
1995
;
92
:
442
–449
485
Michaelsson
M
, Engle MA. Congenital complete heart block: an international study of the natural history.
Cardiovasc Clin
 .
1972
;
4
:
85
–101
486
Solti
F
, Szatmary L, Vecsey T, Renyi-Vamos F, Bodor E. Congenital complete heart block associated with QT prolongation.
Eur Heart J
 .
1992
;
13
:
1080
–1083
487
Silka
MJ
, Manwill JR, Kron J, McAnulty JH. Bradycardia-mediated tachyarrhythmias in congenital heart disease and responses to chronic pacing at physiologic rates.
Am J Cardiol
 .
1990
;
65
:
488
–493
488
Patel
VS
, Lim M, Massin EK. Sudden cardiac death in cardiac transplant recipients.
Circulation
 .
1996
;
94
:
II273
–II277
489
Leonelli
FM
, Dunn JK, Young JB, Pacifico A. Natural history, determinants, and clinical relevance of conduction abnormalities following orthotopic heart transplantation.
Am J Cardiol
 .
1996
;
77
:
47
–51
490
Geelen
P
, Brugada J, Andries E, Brugada P. Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction.
Pacing Clin Electrophysiol
 .
1997
;
20
:
343
–348
491
Kappos
KG
, Kranidis AJ, Anthopoulos LP. Torsades de pointes following radiofrequency catheter His ablation.
Int J Cardiol
 .
1996
;
57
:
177
–179
492
Satoh
T
, Zipes DP. Rapid rates during bradycardia prolong ventricular refractoriness and facilitate ventricular tachycardia induction with cesium in dogs.
Circulation
 .
1996
;
94
:
217
–227
493
Maron
BJ
, Isner JM, McKenna WJ. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse.
J Am Coll Cardiol
 .
1994
;
24
:
880
–885
494
Maron
BJ
. Sudden death in young athletes. Lessons from the Hank Gathers affair.
N Engl J Med
 .
1993
;
329
:
55
–57
495
Maron
BJ
. Cardiovascular risks to young persons on the athletic field.
Ann Intern Med
 .
1998
;
129
:
379
–386
496
Maron
BJ
, Mitten MJ, Quandt EF, Zipes DP. Competitive athletes with cardiovascular disease—the case of Nicholas Knapp.
N Engl J Med
 .
1998
;
339
:
1632
–1635
497
Thompson
PD
, Funk EJ, Carleton RA, Sturner WQ. Incidence of death during jogging in Rhode Island from 1975 through 1980.
JAMA
 .
1982
;
247
:
2535
–2538
498
Siscovick
DS
, Weiss NS, Fletcher RH, Lasky T. The incidence of primary cardiac arrest during vigorous exercise.
N Engl J Med
 .
1984
;
311
:
874
–877
499
Maron
BJ
, Poliac LC, Roberts WO. Risk for sudden cardiac death associated with marathon running.
J Am Coll Cardiol
 .
1996
;
28
:
428
–431
500
Maron
BJ
, Gohman TE, Aeppli D. Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes.
J Am Coll Cardiol
 .
1998
;
32
:
1881
–1884
501
Van Camp
SP
, Bloor CM, Mueller FO, Cantu RC, Olson HG. Nontraumatic sports death in high school and college athletes.
Med Sci Sports Exerc
 .
1995
;
27
:
641
–647
502
Burke
AP
, Farb A, Virmani R, Goodin J, Smialek JE. Sports-related and non-sports-related sudden cardiac death in young adults.
Am Heart J
 .
1991
;
121
:
568
–575
503
Liberthson
RR
. Sudden death from cardiac causes in children and young adults.
N Engl J Med
 .
1996
;
334
:
1039
–1044
504
Virmani
R
, Robinowitz M, McAllister HA Jr. Nontraumatic death in joggers. A series of 30 patients at autopsy.
Am J Med
 .
1982
;
72
:
874
–882
505
Maron
BJ
, Epstein SE, Roberts WC. Causes of sudden death in competitive athletes.
J Am Coll Cardiol
 .
1986
;
7
:
204
–214
506
Maron
BJ
, Pelliccia A, Spirito P. Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy.
Circulation
 .
1995
;
91
:
1596
–1601
507
Pelliccia
A
, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes.
N Engl J Med
 .
1991
;
324
:
295
–301
508
Pelliccia
A
, Culasso F, Di Paolo FM, Maron BJ. Physiologic left ventricular cavity dilatation in elite athletes.
Ann Intern Med
 .
1999
;
130
:
23
–31
509
Pelliccia
A
, Maron BJ, Culasso F, Spataro A, Caselli G. Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes.
JAMA
 .
1996
;
276
:
211
–215
510
Roberts
WC
, Kragel AH. Anomalous origin of either the right or left main coronary artery from the aorta without coursing of the anomalistically arising artery between aorta and pulmonary trunk.
Am J Cardiol
 .
1988
;
62
:
1263
–1267
511
Basso
C
, Maron BJ, Corrado D, Thiene G. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes.
J Am Coll Cardiol
 .
2000
;
35
:
1493
–1501
512
Pelliccia
A
, Maron BJ. Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience [editorial].
Am J Cardiol
 .
1995
;
75
:
827
–829
513
Maron
BJ
, Thompson PD, Puffer JC. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association.
Circulation
 .
1996
;
94
:
850
–856
514
Glover
DW
, Maron BJ. Profile of preparticipation cardiovascular screening for high school athletes.
JAMA
 .
1998
;
279
:
1817
–1819
515
Pfister
GC
, Puffer JC, Maron BJ. Preparticipation cardiovascular screening for collegiate student-athletes.
JAMA
 .
2000
;
283
:
1597
–1599
516
Maron
BJ
, Moller JH, Seidman CE. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases:hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. A statement for healthcare professionals from the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association.
Circulation
 .
1998
;
98
:
1460
–1471
517
Priori
SG
, Broggrefe M, Camm AJ. Role of the implantable cardioverter defibrillator in patients with idiopathic ventricular fibrillation. Data from the UCARE international registry.
Pacing Clin Electrophysiol
 .
2001
;
18
:
799
518
Priori
SG
, Crotti L. Idiopathic ventricular fibrillation.
Cardiac Electrophysiol Rev
 .
1999
;
3
:
198
–201
519
Peeters
HA
, Sippensgroenewegen A, Wever EF. Electrocardiographic identification of abnormal ventricular depolarization and repolarization in patients with idiopathic ventricular fibrillation.
J Am Coll Cardiol
 .
1998
;
31
:
1406
–1413
520
Schaefers
M
, Wichter T, Lerch H. Cardiac 123I-MIBG uptake in idiopathic ventricular tachycardia and fibrillation.
J Nucl Med
 .
1999
;
40
:
1
–5
521
Belhassen
B
, Viskin S. Idiopathic ventricular tachycardia and fibrillation.
J Cardiovasc Electrophysiol
 .
1993
;
4
:
356
–368
522
Phillips
M
, Robinowitz M, Higgins JR, Boran KJ, Reed T, Virmani R. Sudden cardiac death in Air Force recruits. A 20-year review.
JAMA
 .
1986
;
256
:
2696
–2699
523
Lecomte
D
, Fornes P, Fouret P, Nicolas G. Isolated myocardial fibrosis as a cause of sudden cardiac death and its possible relation to myocarditis.
J Forensic Sci
 .
1993
;
38
:
617
–621
524
Fontaine
G
, Fornes P, Fontaliran F, Zipes DP, Wellens HJJ. Myocarditis as a cause of sudden death response.
Circulation
 .
2001
;
103
:
e12
525
Wesslen
L
, Pahlson C, Friman G, Fohlman J, Lindquist O, Johansson C. Myocarditis caused by Chlamydia pneumoniae (TWAR) and sudden unexpected death in a Swedish elite orienteer.
Lancet
 .
1992
;
340
:
427
–428
526
Akhtar
N
, Ni J, Stromberg D, Rosenthal GL, Bowles NE, Towbin JA. Tracheal aspirate as a substrate for polymerase chain reaction detection of viral genome in childhood pneumonia and myocarditis.
Circulation
 .
1999
;
99
:
2011
–2018
527
Basso
C
, Corrado D, Rossi L, Thiene G. Ventricular preexcitation in children and young adults: atrial myocarditis as a possible trigger of sudden death.
Circulation
 .
2001
;
103
:
269
–275
528
Maron
BJ
, Poliac LC, Kaplan JA, Mueller FO. Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities.
N Engl J Med
 .
1995
;
333
:
337
–342
529
Maron
BJ
, Link MS, Wang PJ, Estes NA III. Clinical profile of commotio cordis: an under appreciated cause of sudden death in the young during sports and other activities.
J Cardiovasc Electrophysiol
 .
1999
;
10
:
114
–120
530
Maron
BJ
, Gohman T, Estes N, Link MS. The clinical spectrum of commotio cordis: The first 100 cases from the U.S. Registry.
Circulation
 .
1998
;
102
:
531
Link
MS
, Wang PJ, Pandian NG. An experimental model of sudden death due to low-energy chest-wall impact (commotio cordis).
N Engl J Med
 .
1998
;
338
:
1805
–1811
532
Link
MS
, Wang PJ, VanderBrink BA. Selective activation of the K(+)(ATP) channel is a mechanism by which sudden death is produced by low-energy chest-wall impact (Commotio cordis).
Circulation
 .
1999
;
100
:
413
–418
533
Maron
BJ
, Strasburger JF, Kugler JD, Bell BM, Brodkey FD, Poliac LC. Survival following blunt chest impact-induced cardiac arrest during sports activities in young athletes.
Am J Cardiol
 .
1997
;
79
:
840
–841
534
Haverkamp
W
, Breithardt G, Camm AJ. The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology.
Eur Heart J
 .
2000
;
21
:
1216
–1231
535
Tamargo
J
. Drug-induced torsade de pointes: from molecular biology to bedside.
Jpn J Pharmacol
 .
2000
;
83
:
1
–19
536
Lazzara
R
. Amiodarone and torsade de pointes.
Ann Intern Med
 .
1989
;
111
:
549
–551
537
Hii
JT
, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
Circulation
 .
1992
;
86
:
1376
–1382
538
Mattioni
TA
, Zheutlin TA, Sarmiento JJ, Parker M, Lesch M, Kehoe RF. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
Ann Intern Med
 .
1989
;
111
:
574
–580
539
Crumb
WJ
, Wible B, Arnold DJ, Payne JP, Brown AM. Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity.
Mol Pharmacol
 .
1995
;
47
:
181
–190
540
Suessbrich
H
, Waldegger S, Lang F, Busch AE. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole.
FEBS Lett
 .
1996
;
385
:
77
–80
541
Honig
PK
, Woosley RL, Zamani K, Conner DP, Cantilena LR. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin.
Clin Pharmacol Ther
 .
1992
;
52
:
231
–238
542
Benton
RE
, Honig PK, Zamani K, Cantilena LR, Woosley RL. Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram.
Clin Pharmacol Ther
 .
1996
;
59
:
383
–388
543
Pratt
CM
, Hertz RP, Ellis BE, Crowell SP, Louv W, Moye L. Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine.
Am J Cardiol
 .
1994
;
73
:
346
–352
544
Woosley
RL
. Cardiac actions of antihistamines.
Annu Rev Pharmacol Toxicol
 .
1996
;
36
:
233
–252
545
Antzelevitch
C
, Sun ZQ, Zhang ZQ, Yan GX. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes.
J Am Coll Cardiol
 .
1996
;
28
:
1836
–1848
546
Stramba-Badiale
M
, Guffanti S, Porta N, Frediani M, Beria G, Colnaghi C. QT interval prolongation and cardiac arrest during antibiotic therapy with spiramycin in a newborn infant.
Am Heart J
 .
1993
;
126
:
740
–742
547
Daleau
P
, Lessard E, Groleau MF, Turgeon J. Erythromycin blocks the rapid component of the delayed rectifier potassium current and lengthens repolarization of guinea pig ventricular myocytes.
Circulation
 .
1995
;
91
:
3010
–3016
548
Wiener
I
, Rubin DA, Martinez E, Postman J, Herman MV. QT prolongation and paroxysmal ventricular tachycardia occurring during fever following trimethoprim-sulfamethoxazole administration.
Mt Sinai J Med
 .
1981
;
48
:
53
–55
549
Lopez
JA
, Harold JG, Rosenthal MC, Oseran DS, Schapira JN, Peter T. QT prolongation and torsades de pointes after administration of trimethoprim-sulfamethoxazole.
Am J Cardiol
 .
1987
;
59
:
376
–377
550
Sesti
F
, Abbott GW, Wei J. A common polymorphism associated with antibiotic-induced cardiac arrhythmia.
Proc Natl Acad Sci U S A
 .
2000
;
97
:
10613
–10618
551
Ball
P
. Quinolone-induced QT interval prolongation: a not-so-unexpected class effect.
J Antimicrob Chemother
 .
2000
;
45
:
557
–559
552
Adamantidis
MM
, Dumotier BM, Caron JF, Bordet R. Sparfloxacin but not levofloxacin or ofloxacin prolongs cardiac repolarization in rabbit Purkinje fibers.
Fundam Clin Pharmacol
 .
1998
;
12
:
70
–76
553
Gonzalez
FJ
, Idle JR. Pharmacogenetic phenotyping and genotyping. Present status and future potential.
Clin Pharmacokinet
 .
1994
;
26
:
59
–70
554
Sheets
JJ
, Mason JI, Wise CA, Estabrook RW. Inhibition of rat liver microsomal cytochrome P-450 steroid hydroxylase reactions by imidazole antimycotic agents.
Biochem Pharmacol
 .
1986
;
35
:
487
–491
555
Dumaine
R
, Roy ML, Brown AM. Blockade of HERG and Kv1.5 by ketoconazole.
J Pharmacol Exp Ther
 .
1998
;
286
:
727
–735
556
White
NJ
, Looareesuwan S, Warrell DA. Quinine and quinidine: a comparison of EKG effects during the treatment of malaria.
J Cardiovasc Pharmacol
 .
1983
;
5
:
173
–175
557
Karbwang
J
, Davis TM, Looareesuwan S, Molunto P, Bunnag D, White NJ. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males.
Br J Clin Pharmacol
 .
1993
;
35
:
265
–271
558
Nosten
F
, ter Kuile FO, Luxemburger C. Cardiac effects of antimalarial treatment with halofantrine.
Lancet
 .
1993
;
341
:
1054
–1056
559
Sowunmi
A
, Falade C, Adedeji A. Patterns of change in the electrocardiogram after halofantrine treatment of acute uncomplicated falciparum in children.
Clin Drug Invest
 .
2000
;
20
:
229
–236
560
Bustos
MD
, Gay F, Diquet B, Thomare P, Warot D. The pharmacokinetics and electrocardiographic effects of chloroquine in healthy subjects.
Trop Med Parasitol
 .
1994
;
45
:
83
–86
561
Sartori
M
, Pratt CM, Young JB. Torsade de Pointe. Malignant cardiac arrhythmia induced by amantadine poisoning.
Am J Med
 .
1984
;
77
:
388
–391
562
Mehtonen
OP
, Aranko K, Malkonen L, Vapaatalo H. A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland.
Acta Psychiatr Scand
 .
1991
;
84
:
58
–64
563
Jackson
T
, Ditmanson L, Phibbs B. Torsade de pointes and low-dose oral haloperidol.
Arch Intern Med
 .
1997
;
157
:
2013
–2015
564
Lawrence
KR
, Nasraway SA. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature.
Pharmacotherapy
 .
1997
;
17
:
531
–537
565
Swanson
JR
, Jones GR, Krasselt W, Denmark LN, Ratti F. Death of two subjects due to imipramine and desipramine metabolite accumulation during chronic therapy: a review of the literature and possible mechanisms.
J Forensic Sci
 .
1997
;
42
:
335
–339
566
Wysowski
DK
, Bacsanyi J. Cisapride and fatal arrhythmia.
N Engl J Med
 .
1996
;
335
:
290
–291
567
Henney
J
. Withdrawal of troglitazone and cisapride.
JAMA
 .
2000
;
283
:
2228
568
Herlitz
J
, Bahr J, Fischer M, Kuisma M, Lexow K, Thorgeirsson G. Resuscitation in Europe: a tale of five European regions.
Resuscitation
 .
1999
;
41
:
121
–131
569
Valenzuela
TD
, Roe DJ, Nichol G, Clark LL, Spaite DW, Hardman RG. Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos.
N Engl J Med
 .
2000
;
343
:
1206
–1209
570
Holmberg
M
, Holmberg S, Herlitz J, Gardelov B. Survival after cardiac arrest outside hospital in Sweden. Swedish Cardiac Arrest Registry.
Resuscitation
 .
1998
;
36
:
29
–36
571
Tunstall-Pedoe
H
, Bailey L, Chamberlain DA, Marsden AK, Ward ME, Zideman DA. Survey of 3765 cardiopulmonary resuscitations in British hospitals (the BRESUS Study): methods and overall results.
BMJ
 .
1992
;
304
:
1347
–1351
572
Mullie
A
, Lewi P, Van Hoeyweghen R. Pre-CPR conditions and the final outcome of CPR. The Cerebral Resuscitation Study Group.
Resuscitation
 .
1989
;
17
:
S11
–S21
573
Becker
LB
, Ostrander MP, Barrett J, Kondos GT. Outcome of CPR in a large metropolitan area—where are the survivors?
Ann Emerg Med
 .
1991
;
20
:
355
–361
574
Circulation
 .
2000
;
102
:
575
JAMA
 .
1974
;
227
:
833
–868
576
Bossaert
L
. European Resuscitation Council guidelines for Resuscitation. Amsterdam: Elsevier; 1998.
577
Cummins
RO
, Chamberlain DA. Advisory statements of the International Liaison Committee on Resuscitation.
Circulation
 .
1997
;
95
:
2172
–2173
578
Resuscitation
 .
2000
;
46
:
1
–448
579
Kern
KB
, Sanders AB, Raife J, Milander MM, Otto CW, Ewy GA. A study of chest compression rates during cardiopulmonary resuscitation in humans. The importance of rate-directed chest compressions.
Arch Intern Med
 .
1992
;
152
:
145
–149
580
Schneider
T
, Martens PR, Paschen H. Multicenter, randomized, controlled trial of 150-J biphasic shocks compared with 200- to 360-J monophasic shocks in the resuscitation of out-of-hospital cardiac arrest victims.
Circulation
 .
2000
;
102
:
1780
–1787
581
Cummins
RO
, Chamberlain D, Hazinski MF. Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital 'Utstein style'. A statement for healthcare professionals from the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, the Australian Resuscitation Council, and the Resuscitation Councils of Southern Africa.
Resuscitation
 .
1997
;
34
:
151
–183
582
White
RD
, Asplin BR, Bugliosi TF, Hankins DG. High discharge survival rate after out-of-hospital ventricular fibrillation with rapid defibrillation by police and paramedics.
Ann Emerg Med
 .
1996
;
28
:
480
–485
583
Mosesso
VN
Jr
, Davis EA, Auble TE, Paris PM, Yealy DM. Use of automated external defibrillators by police officers for treatment of out-of-hospital cardiac arrest.
Ann Emerg Med
 .
1998
;
32
:
200
–207
584
O'Rourke
MF
, Donaldson E, Geddes JS. An airline cardiac arrest program.
Circulation
 .
1997
;
96
:
2849
–2853
585
Page
RL
, Hamdan MH, McKenas DK. Defibrillation aboard a commercial aircraft.
Circulation
 .
1998
;
97
:
1429
–1430
586
Weisfeldt
ML
, Kerber RE, McGoldrick RP, Moss AJ, Nichol G, Ornato JP, Palmer DG, Riegel B, Smith SC Jr. Public access defibrillation. A statement for healthcare professionals from the American Heart Association Task Force on Automatic External Defibrillation.
Circulation
 .
1995
;
92
:
2763
This content is only available as a PDF.

Comments

0 Comments